1. Immunotherapy for Acute Myelogenous Leukaemia
2. Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient
3. R. Peto, In: D. Windhorst, W. Terry (Eds), Immunotherapy of Cancer: Present Status of Trials in Man; Progress in Cancer Research and Therapy vol. 5 (New York (in the press)).
4. P. Reizenstein, L. Brenning, L. Engstodt, S. Franzen, G. Gahrton, B. Gullbring, G. Holm, P. Hockor, S. Hogland, P. Hornston, S. Hameson, A. Killander, D. Killander, E. Klein, B. Lantz, C.L. Lindemalm, D. Locker, B. Lonnquist, H. Mellstedt, J. Palmblad, C. Pauli, K.O. Skarberg, A.M. Uden, F. Vanky, B. Wadman, In: D. Windhorst, W. Terry (Eds), Immunotherapy of Cancer: Present Status of Trials in Man; Progress in Cancer Research and Therapy vol. 5 (New York (in the press)).
5. Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study